Is Metabolic Acidosis a Friend or Foe for Cardiovascular Disease in Kidney Transplant Recipients?

被引：0
|
作者：
Woodell, Tyler B. [1 ]
Ix, Joachim H. [1 ,2 ,3 ]
机构：
[1] Univ Calif San Diego, Dept Med, Div Nephrol Hypertens, San Diego, CA 92103 USA
[2] Vet Affairs San Diego Healthcare Syst, Nephrol Sect, La Jolla, CA USA
[3] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Prevent Med, San Diego, CA 92103 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2019年 / 73卷 / 04期
关键词：
SERUM BICARBONATE; RISK; ASSOCIATION; FIBROSIS; MARKERS; CKD;
D O I：
10.1053/j.ajkd.2019.01.006
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：465 / 466
页数：2
相关论文
共 50 条
  • [41] Secular Trends in Cardiovascular Disease Among Kidney Transplant Recipients.
    Lam, N.
    Naylor, K.
    Shariff, S.
    McArthur, E.
    Knoll, G.
    Kim, S.
    Garg, A.
    [J]. TRANSPLANTATION, 2014, 98 : 520 - 520
  • [42] Secular Trends in Cardiovascular Disease Among Kidney Transplant Recipients.
    Lam, N.
    Naylor, K.
    Shariff, S.
    McArthur, E.
    Knoll, G.
    Kim, S.
    Garg, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 520 - 520
  • [43] Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease
    Ait-Aissa, Karima
    Ebben, Johnathan D.
    Kadlec, Andrew O.
    Beyer, Andreas M.
    [J]. PHARMACOLOGICAL RESEARCH, 2016, 111 : 422 - 433
  • [44] Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: The FAVORIT Trial
    Weiner, D. E.
    Carpenter, M. A.
    Levy, A. S.
    Ivanova, A.
    Cole, E. H.
    Hunsicker, L.
    Kasiske, B. L.
    Kim, S. J.
    Kusek, J. W.
    Bostom, A. G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (09) : 2437 - 2445
  • [45] S-glutathionylation, friend or foe in cardiovascular health and disease
    Rashdan, N. A.
    Shrestha, B.
    Pattillo, C. B.
    [J]. REDOX BIOLOGY, 2020, 37
  • [46] Phosphoinositide 3-kinase: friend and foe in cardiovascular disease
    Ghigo, Alessandra
    Li, Mingchuan
    [J]. FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [47] The Wnt/frizzled pathway in cardiovascular development and disease: Friend or foe?
    van de Schans, Veerle A. M.
    Smits, Jos F. M.
    Blankesteijn, W. Matthijs
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 585 (2-3) : 338 - 345
  • [48] The effects of Thrombospondin-1 on cardiovascular disease: Friend or foe?
    Mo, Degang
    Liu, Jiahui
    Li, Hongxu
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 377 : 19 - 19
  • [49] Insulin treatment and cardiovascular disease; friend or foe? A point of view
    Muis, MJ
    Bots, ML
    Grobbee, DE
    Stolk, RP
    [J]. DIABETIC MEDICINE, 2005, 22 (02) : 118 - 126
  • [50] Metabolic Acidosis and Cardiovascular Disease in CKD
    Collister, David
    Ferguson, Thomas W.
    Funk, Susan E.
    Reaven, Nancy L.
    Mathur, Vandana
    Tangri, Navdeep
    [J]. KIDNEY MEDICINE, 2021, 3 (05) : 753 - +
12345